Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial.
Journal
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040
Informations de publication
Date de publication:
16 May 2023
16 May 2023
Historique:
pmc-release:
17
07
2024
medline:
10
11
2023
pubmed:
10
11
2023
entrez:
10
11
2023
Statut:
aheadofprint
Résumé
The multicentre European Bifurcation Club Trial (EBC TWO) showed no significant differences in 12-month clinical outcomes between patients randomised to a provisional stenting strategy or systematic culotte stenting in non-left main true bifurcations. This study aimed to investigate the 5-year clinical results of the EBC TWO Trial. A total of 200 patients undergoing stent implantation for non-left main bifurcation lesions were recruited into EBC TWO. Inclusion criteria required a side branch diameter ≥2.5 mm and side branch lesion length >5 mm. Five-year follow-up was completed for 197 patients. The primary endpoint was the composite of all-cause mortality, myocardial infarction, or target vessel revascularisation. The mean side branch stent diameter was 2.7±0.3 mm and mean side branch lesion length was 10.3±7.2 mm. At 5-year follow-up, the primary endpoint occurred in 18.4% of provisional and 23.7% of systematic culotte patients (hazard ratio [HR] 0.75, 95% confidence interval [CI]: 0.41-1.38). No significant differences were identified individually for all-cause mortality (7.8% vs 7.2%, HR 1.11, 95% CI: 0.40-3.05), myocardial infarction (8.7% vs 13.4%, HR 0.64, 95% CI: 0.27-1.50) or target vessel revascularisation (6.8% vs 9.3%, HR 1.12, 95% CI: 0.37-3.34). Stent thrombosis rates were also similar (1.9% vs 3.1%, HR 0.63, 95% CI: 0.11-3.75). There was no significant interaction between the extent of side branch disease and the primary outcome (p=0.34). In large non-left main true bifurcation lesions, the use of a systematic culotte strategy showed no benefit over provisional stenting for the composite outcome of all-cause mortality, myocardial infarction, or target vessel revascularisation at 5 years. The stepwise provisional approach may be considered preferable for the majority of true coronary bifurcation lesions. gov: NCT01560455.
Sections du résumé
BACKGROUND
BACKGROUND
The multicentre European Bifurcation Club Trial (EBC TWO) showed no significant differences in 12-month clinical outcomes between patients randomised to a provisional stenting strategy or systematic culotte stenting in non-left main true bifurcations.
AIMS
OBJECTIVE
This study aimed to investigate the 5-year clinical results of the EBC TWO Trial.
METHODS
METHODS
A total of 200 patients undergoing stent implantation for non-left main bifurcation lesions were recruited into EBC TWO. Inclusion criteria required a side branch diameter ≥2.5 mm and side branch lesion length >5 mm. Five-year follow-up was completed for 197 patients. The primary endpoint was the composite of all-cause mortality, myocardial infarction, or target vessel revascularisation.
RESULTS
RESULTS
The mean side branch stent diameter was 2.7±0.3 mm and mean side branch lesion length was 10.3±7.2 mm. At 5-year follow-up, the primary endpoint occurred in 18.4% of provisional and 23.7% of systematic culotte patients (hazard ratio [HR] 0.75, 95% confidence interval [CI]: 0.41-1.38). No significant differences were identified individually for all-cause mortality (7.8% vs 7.2%, HR 1.11, 95% CI: 0.40-3.05), myocardial infarction (8.7% vs 13.4%, HR 0.64, 95% CI: 0.27-1.50) or target vessel revascularisation (6.8% vs 9.3%, HR 1.12, 95% CI: 0.37-3.34). Stent thrombosis rates were also similar (1.9% vs 3.1%, HR 0.63, 95% CI: 0.11-3.75). There was no significant interaction between the extent of side branch disease and the primary outcome (p=0.34).
CONCLUSIONS
CONCLUSIONS
In large non-left main true bifurcation lesions, the use of a systematic culotte strategy showed no benefit over provisional stenting for the composite outcome of all-cause mortality, myocardial infarction, or target vessel revascularisation at 5 years. The stepwise provisional approach may be considered preferable for the majority of true coronary bifurcation lesions.
CLINICALTRIALS
RESULTS
gov: NCT01560455.
Identifiants
pubmed: 37946522
pii: EIJ-D-23-00211
doi: 10.4244/EIJ-D-23-00211
pmc: PMC10333921
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT01560455']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Am Coll Cardiol. 2011 Feb 22;57(8):914-20
pubmed: 21329837
Open Heart. 2020 Jan 19;7(1):e000947
pubmed: 32076558
J Am Coll Cardiol. 2013 Jul 2;62(1):30-4
pubmed: 23644088
Circ Cardiovasc Interv. 2017 Feb;10(2):
pubmed: 28122805
Circ Cardiovasc Interv. 2016 Sep;9(9):
pubmed: 27578839
Circulation. 2010 Mar 16;121(10):1235-43
pubmed: 20194880
Eur Heart J. 2016 Jun 21;37(24):1923-8
pubmed: 27161619
EuroIntervention. 2022 Aug 19;18(6):457-470
pubmed: 35570753
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1432-1444
pubmed: 32553331
J Am Coll Cardiol. 2000 Sep;36(3):959-69
pubmed: 10987628
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
EuroIntervention. 2019 Aug 29;15(5):465-472
pubmed: 30530401
EuroIntervention. 2015 Dec;11(8):856-9
pubmed: 26696453
JACC Cardiovasc Interv. 2022 Jun 27;15(12):1231-1242
pubmed: 35595676
Circulation. 2018 Jun 12;137(24):2635-2650
pubmed: 29891620
EuroIntervention. 2021 Dec 03;17(11):e910-e918
pubmed: 33970107